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Currently, global indices that summarize the visual ﬁeld combine sensitivities on a logarithmic (decibel)
scale. Recent structure–function models for glaucoma suggest that contrast sensitivity should be con-
verted to a linear scale before averaging across visual ﬁeld locations, to better relate sensitivity with
the number of surviving retinal ganglion cells (RGCs). New indices designed to represent the number
of RGCs already lost are described. At least one was found to be a signiﬁcantly better predictor of subse-
quent rate of change than traditional Mean Deviation (p = 0.014) in participants with glaucomatous optic
neuropathy. Issues concerning the creation of optimal global indices are discussed.
 2011 Elsevier Ltd. All rights reserved.1. Introduction
Primary open-angle glaucoma is characterized by loss of retinal
ganglion cells (RGCs). Therefore, when assessing the visual ﬁeld in
order to predict the future rate of functional progression, it would
appear reasonable to assess and predict the rate of RGC loss. Both
structural and functional tests for glaucoma may be regarded as
surrogates for measuring the current number of functioning RGCs.
These surrogate measures are imperfect, as they are affected by be-
tween-participant and within-participant variability, as well as
non-pathologic neural factors. These imperfections are evidenced
by the observed weakness of the cross sectional and longitudinal
structure–function relations (Anderson, 2006; Bowd et al., 2006;
Caprioli, 1989; Gardiner, Johnson, & Ciofﬁ, 2005; Strouthidis
et al., 2006) Recently, work has been conducted to link more accu-
rately results from perimetric and imaging measures to RGC counts
(Drasdo, Mortlock, & North, 2008; Garway-Heath, Caprioli, Fitzke,
& Hitchings, 2000; Harwerth, Vilupuru, Rangaswamy, & Smith,
2007; Harwerth et al., 2002, 2004; Hood, 2007; Hood, Anderson,
Wall, & Kardon, 2007; Hood, Anderson, Wall, Raza, & Kardon,
2009; Hood & Kardon, 2007). Contrast sensitivity measured during
perimetry is generally reported in decibels (dB); for the most com-
monly used perimetric stimuli, 1 dB difference represents a change
of 0.1 log10 units of light attenuation, where attenuation is the re-ll rights reserved.
te, Legacy Research Institute,
503 413 5179.
diner).ciprocal of the stimulus luminance in candelas per meter squared
(cd/m2) or apostilbs (asb), where 1 cd/m2 = p asb. These papers
have suggested that perimetric sensitivity values should be trans-
formed from the dB scale to a linear scale before they are averaged,
as this may result in better correlations with RGC counts. It is
therefore prudent to consider the use of linear-scaled global indi-
ces as summary measures of the visual ﬁeld, as possible alterna-
tives to the current decibel-based measures such as Mean
Deviation (MD).
Recognizing when a patient’s vision is deteriorating rapidly is a
key aspect of glaucoma follow-up, so that appropriate manage-
ment strategies can be implemented to slow or halt progression.
However, measuring and predicting rates of progression remains
challenging. Non-perimetric indices have been found to be associ-
ated with an increased probability of future progression, and/or a
more rapid rate of future progression. These include higher
Intraocular Pressure (IOP) (Friedman, Wilson, Liebmann, Fechtner,
& Weinreb, 2004; Gordon et al., 2002; Leske et al., 2003;
Nouri-Mahdavi et al., 2004), greater IOP ﬂuctuation (Hong, Seong,
& Hong, 2007; Nouri-Mahdavi et al., 2004), increased age (Broman
et al., 2008; Friedman et al., 2004; Gordon et al., 2002; Leske et al.,
2003; Nouri-Mahdavi et al., 2004) and belonging to certain racial
groupings (Broman et al., 2008; Drance, Anderson, & Schulzer,
2001; Gordon et al., 2002), although some of these factors have
been disputed (Bengtsson, Leske, Hyman, & Heijl, 2007; Drance
et al., 2001; Friedman et al., 2004). Even after taking these factors
into account, the current status of the patient’s visual ﬁeld may
also be a predictor of their functional prognosis (Gardiner, Demirel,
1802 S.K. Gardiner et al. / Vision Research 51 (2011) 1801–1810& Johnson, 2011; Leske et al., 2003), with patients exhibiting more
severe functional loss being at higher risk of more rapid subse-
quent progression.
This study derives linear-based indices from published struc-
ture–function models that have been designed to reﬂect the num-
ber or loss of RGCs. They are then compared to current decibel-
based indices in terms of their ability to predict subsequent rate
of change in eyeswith high-risk ocular hypertension and early glau-
coma. Issues surrounding the design of an optimal global index are
then discussed. While it is unlikely that clinical decisions concern-
ing progression would be made on the basis of just one visual ﬁeld
modality without considering other factors, an index showing im-
proved prognostic ability in isolationwould be expected to improve
the overall prognostic ability when additional information is added.
The overall goal of this project is to develop indices that can be used
for identiﬁcation of participants at higher risk of rapid subsequent
functional progression, so that their management can be tailored
appropriately, while also learning more about the disease process.Table 1
Baseline characteristics of the study population.
Participants with GON Participants without GON
Mean Standard deviation Mean Standard deviation
Age (years) 57.2 10.5 53.4 8.9
MD (dB) 0.31 2.56 0.93 2.07
PSD (dB) 6.14 1.94 5.27 1.212. Methods
2.1. Data
Data for this study were obtained from an ongoing longitudinal
study of progression in participants with early and suspected glau-
coma, at Devers Eye Institute in Portland, Oregon, USA. The study
adheres to the tenets of the Declaration of Helsinki, complies with
the United States Health Insurance Portability and Accountability
Act of 1996 (HIPAA), and the protocol was approved by the Institu-
tional Review Board at Legacy Health. Each participant provided
written informed consent, after having the risks and beneﬁts of
participation explained to them.
Participants were tested annually with a variety of structural
and functional tests (Gardiner et al., 2005; Spry, Johnson, Mansber-
ger, & Ciofﬁ, 2005). In 93% of cases, testing took place within
2 months of the same date as the previous year (mean interval
368 days, standard deviation 62 days). At study entry, participants
had either a clinical diagnosis of early glaucoma, or ocular hyper-
tension (untreated IOP P22 mmHg on more than one occasion)
plus one or more possible risk factors for glaucoma as determined
by their clinician (age > 70, systemic hypertension, diet controlled
diabetes, peripheral vasospasm, African ancestry or self-reported
family history of glaucoma) and/or previously diagnosed glauco-
matous optic neuropathy (GON) or suspicious optic nerve head
appearance (cup-disc ratio asymmetry >0.2, neuroretinal rim
notching or narrowing, disc hemorrhage) (Gardiner et al., 2005;
Spry et al., 2005). Participants who had other serious ocular dis-
eases or who were using medications likely to affect the visual
ﬁeld, or who had undergone ocular surgery (except for uncompli-
cated cataract surgery), were excluded. In addition, glaucoma par-
ticipants with visual acuity worse than 20/40 in either eye or with
MD from standard automated perimetry worse than 6 dB at
enrollment were excluded to minimize potentially compromising
factors such as cataract and higher variability associated with more
advanced glaucoma.
Visual ﬁeld tests were performed with a Humphrey Field Ana-
lyzer II (Carl Zeiss Meditec Inc., Dublin, CA, USA). The 24-2 testing
pattern and conventional test procedures were employed (Ander-
son & Patella, 1999). For the current analysis only ﬁelds collected
with the SITA standard algorithm (Bengtsson, Olsson, Heijl, & Root-
zen, 1997) were used. An optimal lens correction was placed before
the tested eye, and the fellow eye was occluded with a translucent
eye patch. All participants had undergone at least one visual ﬁeld
test prior to entering the study. In addition, stereo optic nerve head
photos (3-Dx, Nidek Co. Ltd., Gamagori, Japan) taken at each partic-ipant’s initial visit were evaluated to determine whether the eyes
exhibited GON. Optic nerve heads were classiﬁed as either GON
or within limits of normal appearance by two masked experienced
fellowship-trained glaucoma specialists, with adjudication by a
third masked glaucoma specialist if consensus was not reached
(Fortune et al., 2007). This was recorded along with age at baseline,
IOP at baseline measured by Goldmann Applanation Tonometry
(Haag-Streit, Bern, Switzerland) with the participant seated at a slit
lamp, and treatment status (whether the patient reported that they
were taking ocular hypotensive medications prescribed by their
eye care specialist).
For inclusion in this study, participants were required to have
performed reliable SITA standard visual ﬁeld tests (633% ﬁxation
losses, 615% false positives) at seven or more annual visits (i.e.
over a 6 year period). All such participants were included. False
negative rates were not considered for reliability because they in-
crease with visual ﬁeld loss due to higher variability of response in
damaged visual ﬁeld areas (Bengtsson & Heijl, 2000). If results
from more than seven annual visual ﬁeld tests were available, data
from the seven most recent tests were used. To increase the range
of rates of change in the dataset and so make the conclusions more
generalizable, the fastest changing eye of each participant was cho-
sen as detailed below. In total, 95 participants satisﬁed these entry
criteria. These were split for analysis into two cohorts; 50 partici-
pants exhibiting GON at baseline (who are therefore assumed to
have glaucoma), and 45 participants with optic disc appearance
within normal limits at baseline (who are assumed to have either
very early glaucoma or moderate- to high-risk ocular hyperten-
sion). The non-GON cohort can be thought of as an independent
dataset to test indices that appear useful based on results from
the GON cohort, although the reduced severity and range of disease
may hinder the ability to draw ﬁrm conclusions. Age, MD and Pat-
tern Standard Deviation (PSD) for these two groups at the ﬁrst of
the seven visits used in this study are summarized in Table 1.
The study population is 95% white due to the demographics of
the region in which the study was conducted. The new Visual Field
Index (VFI) (Bengtsson & Heijl, 2008) had a median value of 99.6%
of ‘normal vision’ in the GON cohort at the ﬁrst visit, and a median
of 99.9% in the participants without GON; MD was used in prefer-
ence to VFI to assess progression in this cohort due to the ceiling
effect that is present for VFI in early glaucoma (Artes et al., 2011).2.2. Indices
The indices described here generate an estimate of the RGC
count across the central visual ﬁeld. They do this by estimating
the RGC count at each location, and then averaging this across loca-
tions. However, if it were assumed that each individual RGC has a
constant statistical hazard over the duration of the study (i.e. the
probability of the RGC dying in the next month is constant, inde-
pendent of how many months have already passed, giving a con-
stant percentage loss of remaining RGCs per unit time), then the
total RGC count would decline exponentially over time. This would
manifest as a linear reduction in the logarithm of the RGC count.
Therefore, the indices are transformed back onto a decibel scale
after the process of averaging over locations. This makes linear
Table 2
Summary of the indices considered in this study. Additionally, a capped version of each index (except MD) was calculated, in which all sensitivities were constrained to no more
than the age-corrected normal value before the index was calculated; these are referred to as LMS(cap), etc.
Index
name
Description Structure–
function
model used
Based
on
RGC count
adjusted
for
Formula for one location Other parameters
MD Mean decibel
deviation from
normal
TDdB Age TDdB
LMS Mean linear
deviation from
normal
SensLin SensLin
CountG RGC count Garway-Heath
et al.
SensLin Eccentricity SensLin = 392 + (208  CountG)k k is an eccentricity-dependent
scaling factor
CountHa RGC count Harwerth
et al.
SensdB Eccentricity CountHa = (SensdB  b)/m m = 0.95 + (0.054  e)
b = 14.8  (1.5  e)
e = eccentricity
LossHo RGC loss Hood et al. TDLin Age TDLin
CountD RGC density Drasdo et al. SensLin Below 29 dB: CountD = 0.2065
 SensLin
Above 29 dB:
CountD ¼ 191:1 1:088  SensLin þ 0:003101 
Sens2Lin  0:00000319  Sens3Lin þ 0:00000001223  Sens4Lin
CountDA RGC density Drasdo et al. TDLin Age Same as CountD SensLin replaced by
TDLin + Sens60, the normal
sensitivity at age 60
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functional change. This choice eases interpretation compared to
exponential regression of linear scaled indices, and is applied to
all the indices.
Sensitivity values at each location are reported by the Hum-
phrey perimeter in two formats, as raw dB sensitivity and as a total
deviation (TD), the latter representing how much higher or lower
the sensitivity is compared with an age-corrected and location-
speciﬁc normal database. Each of these can be expressed either
in dB (as output by the perimeter), or transformed onto a linear
scale by the transformations SensdB = 10  log10(SensLin) and TDdB
= 10  log10(TDLin); equivalently, SensLin = 10SensdB/10 and TDLin =
10TDdB/10.
Six summary measures of the visual ﬁeld were used.
1. LMS: Linear Mean Sensitivity. The arithmetic mean of the linear
sensitivity values SensLin, transformed back onto a decibel scale
(Hot, Dul, & Swanson, 2008; Yang & Swanson, 2007).
2. CountG: The RGC count according to a model published by
Garway-Heath et al. (2000). At each location, this is given by
SensLin = 392 + (208  Count)k where k is an eccentricity-
dependent coefﬁcient of summation. This count is averaged
over all 52 locations and then transformed back onto a decibel
scale.
3. CountHa: The RGC count according to a model published by
Harwerth and Quigley (2006) and Harwerth et al. (2004). At
each location, the RGC count in dB is given by (SensdB  b)/m,
where m = 0.95 + (0.054  e) and b = 14.8  (1.5  e), with e
being the retinal eccentricity in degrees. These RGC counts are
then transformed into linear units, averaged (arithmetic mean),
and then converted back onto a decibel scale.
4. LossHo: The loss of RGCs according to a model published by
Hood (2007), Hood and Kardon (2007) and Hood et al. (2007).
At each location, this is given by the total deviation expressed
in linear units, TDLin. The arithmetic mean of these values is
then converted back onto a decibel scale.
5. CountD: The RGC density according to a model published by
Drasdo et al. (2008). Below 29 dB, this is given by den-
sity = 0.2065  SensLin. Above 29 dB, a non-linear relation
applies, given by density ¼ 191:1 1:088  SensLin þ 0:003101 Sens2Lin  0:00000319  Sens3Lin þ 0:00000001223  Sens4Lin.
As above, these values were averaged across locations, and then
converted back to a decibel scale.
6. CountDA: The RGC density according to the model published by
Drasdo et al. as above, but after the sensitivities have been age-
corrected (Drasdo et al., 2008). The equations were based on a
participant of age 60; therefore, the sensitivity SensdB was
age-adjusted accordingly before it was converted to linear
units, by addition of the normal sensitivity at that location at
age 60 to the total deviation TDdB.
For reference, results using Mean Deviation (MD) are also re-
ported. A summary of all the indices considered is given in Table 2.
Note that the published models produce RGC counts across dif-
ferent areas of the retina, and so the resultant indices may differ by
(on the dB scale) an additive constant. This was not corrected for,
to maintain equivalence with the published works. An additive
constant offset will not affect any of the results for predictability
or comparisons between the prognostic utility of the indices. By
the same logic, it makes no difference whether values are summed
or averaged across locations (giving RGC counts differing by a mul-
tiplicative constant of 52 on the linear scale, and hence by an addi-
tive constant of 17.2 dB). Although we refer to indices as
representing RGC count for brevity, in fact some indices represent
RGC count, some RGC loss and some RGC density. However, this
does not affect comparisons when converted to a decibel scale.
While these models have been derived to predict RGC counts in
eyes with glaucoma, there is considerable variability among nor-
mal eyes. The relation between retinal nerve ﬁber layer thickness
(a presumed surrogate for RGC count) and sensitivity in normal
eyes is weak (Hood et al., 2007). For this reason, the model de-
scribed by Hood et al. was derived based on the amount of damage,
without above-normal sensitivities. Also, the SITA standard algo-
rithm is designed to minimize errors on a dB scale. Therefore as
an example, a true sensitivity of 34 dB being measured as 36 dB
due to 2 dB measurement error corresponds to an error of 1470 lin-
ear (1/contrast) units; whereas a true sensitivity of 16 dB being
measured as 18 dB corresponds to an error of only 23 units on
the same linear scale. This means that apparently small measure-
ment errors at locations with normal and above-normal sensitivity
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compared with the same dBmeasurement error at a damaged loca-
tion, when the overall index is generated by calculation of the aver-
age over all locations. Due to these factors, it may be a reasonable
tradeoff to suggest that the new global indices could perform bet-
ter if the sensitivities at each location were ‘capped’ at normal, to
effectively provide an estimate of RGC loss due to glaucoma, rather
than the existing RGC count. Hence, all seven indices were recalcu-
lated after sensitivity values were capped at each individual loca-
tion, so that the capped TDdB has a maximum of zero, and the
capped SensdB has a maximum of the age-referenced normal value.
These will be referred to as LMS(cap), etc.
2.3. Analyses
For each of the 13 indices (the six indices enumerated above,
both capped and uncapped in each case, plus traditional MD), base-
line values were calculated (the value in year 1 of the series), to-
gether with the subsequent slope, deﬁned as the slope of a linear
regression of that index over years 2–7 of the series. The aim is
then to ﬁnd the baseline index that best predicts subsequent slope,
i.e. the rate of subsequent functional progression. An improved
ability of an index to predict subsequent change of that same index
illustrates that the relation between its value and its rate of change
is less variable, and hence it may be useful as a prognostic indicator
However, an index with a ﬁxed value of zero would be perfectly
predictable over time, yet uninformative about the status of the vi-
sual ﬁeld. Therefore, it is necessary also to test the ability of the in-
dex to predict subsequent changes in an index that is already
known to represent the visual ﬁeld status. Subsequent slope of
MD was chosen as the outcome measure for this purpose. In all
analyses below, the baseline value of an index is used to predict
both its own subsequent slope and the subsequent slope of MD.
This subsequent slope of MD was also used to deﬁne the fastest
changing eye for each participant, for use in all analyses.
Linear regression was used to predict subsequent slope of MD
based on the value of each of the indices in turn, plus IOP, treat-
ment status and age, measured at baseline. Of the 95 participants,
three had missing IOP readings at baseline and so were excluded
from these analyses. Stepwise backwards elimination was used
to exclude the least signiﬁcant predictor at each stage, to maximize
the adjusted R2 of the ﬁt. The value of the index being considered
as a predictor was not eligible for elimination from the regression
during this process. Once backwards elimination had been com-
pleted, the adjusted R2 of the ﬁnal model was recorded, as a mea-
sure of how well the index predicts the subsequent slope of MD
after other factors have been accounted for. The correlation be-
tween the actual subsequent slope and that predicted by the model
for each participant was compared against the equivalent correla-
tion for MD predicting the subsequent slope of MD, to determine
whether the index demonstrated signiﬁcantly better predictability,
using the Z2 test statistic (Steiger, 1980).
After this had been carried out for all predictor indices, the pro-
cess was repeated when the indices were used to predict their own
subsequent slopes, instead of the slope of MD. Analyses were car-
ried out both for the 49 participants exhibiting GON at the initial
visit (excluding one of the 50 GON participants with missing base-
line IOP), referred to as the GON cohort, and also for the remaining
43 participants (excluding two participants with no baseline IOP),
referred to as the non-GON cohort.
Use of a linear regression model such as that above to predict
subsequent slope relies on implicit assumptions about the relation
between the predictor and the outcome. Therefore, non-parametric
analyses were also carried out, which do not require such stringent
assumptions for validity. These cannot predict the actual subse-
quent slope, but aim instead to predict the ranking of the subse-quent slope, i.e. to identify the participants likely to undergo the
most rapid rate of subsequent change. Firstly, the Spearman rank
correlations between the value of an index at baseline and the sub-
sequent slopes of MD and of the same index were calculated for
both cohorts. To determine whether correlations were signiﬁcantly
better than that predicting subsequent slope of MD from baseline
MD, the same Z2 statistic was used as before.
The participants were then divided into tertiles based on their
subsequent rate of progression as measured by the subsequent
slope of MD and of each other index in turn. Note that this may re-
sult in participants being placed in different tertiles for different
indices. Tertiles were chosen over other possible categorizations
to ensure a reasonable sample size in each (Kass et al., 2010). Wil-
coxon rank sum tests were performed to compare the baseline val-
ues of the indices between participants in the worst tertile (most
rapid progression) and participants in the other two tertiles. Then,
logistic regression was performed to predict the probability that a
participant would be in the worst tertile, with the baseline index
value, age, IOP and treatment status as predictors. Stepwise back-
wards elimination was used to minimize the Akaike Information
Criterion; AIC = 2k  2 ln(L), where k is the number of parameters
in the statistical model and L is the maximized value of the likeli-
hood function for the estimated model, to give a measure of good-
ness-of-ﬁt for the model that penalizes over-ﬁtting by inclusion of
too many predictors. Nagelkerke’s pseudo-R2 coefﬁcient of deter-
mination was used to assess the strength of association in the ﬁnal
model (Nagelkerke, 1991). These analyses are designed to evaluate
whether the baseline value of an index could be used to identify
those participants most likely to undergo more rapid subsequent
progression, since these are the most crucial participants to iden-
tify in a clinical situation. Again, the tests were repeated for both
cohorts.3. Results
Table 3 shows results from the parametric linear regression
analysis. When the subsequent slope of the same index is pre-
dicted, the two indices based on RGC count showed signiﬁcantly
worse predictive power than MD in the GON cohort; CountG
(p = 0.012) and CountG(cap) (p = 0.043). The best predictor was
RGC loss, LossHo(cap), which showed greater predictive power than
MD for the GON participants (p = 0.014). While other indices also
produced greater adjusted R2 values than MD, for both the GON
and non-GON cohorts, none reached statistical signiﬁcance
(p > 0.10 in all cases).
Table 4 presents non-parametric Spearman correlation coefﬁ-
cients between baseline values of each index and the subsequent
slopes both of the same index and of MD. CountG again performed
signiﬁcantly worse than MD in the GON cohort (p = 0.029). Count-
DA(cap) performed signiﬁcantly better in the GON cohort
(p = 0.035); LossHo(cap) performed better in both cohorts
(p = 0.031 for GON, and p = 0.012 for non-GON). Note that these
rank correlations can appear artiﬁcially high when tied observa-
tions occur in the dataset. In particular, for the capped indices,
there are multiple ﬁelds in the dataset for which the index value
is the same (since every test location was at or above the age-cor-
rected normal sensitivity), especially in the non-GON cohort.
Therefore, correlations for these capped indices should be inter-
preted with caution; they are reported here for completeness.
Table 5 presents p-values fromWilcoxon rank sum test compar-
isons of the baseline values of each index between the worst tertile
for subsequent rate of change (as deﬁned either by the slope of MD,
or the slope of the same index) and the remaining participants. Al-
most all indices showed signiﬁcant differences in the GON cohort
whichever tertiles were used. In the non-GON cohort, only three
Table 3
Adjusted R2 of models that use the baseline value of each index to predict the subsequent rate of change. Values in bold were signiﬁcantly different (better or worse) from the
model that used MD to predict subsequent slope of MD (p < 5%). A backwards-elimination linear regression model was used as outlined in Section 2. Deﬁnitions of each index are
given in Section 2. The indices labeled ‘cap’ are calculated after pointwise sensitivities were capped at the age-corrected normal value.
Baseline
index
Based on model
from
Participants with GON Participants without GON
Adjusted R2 predicting slope
of MD
Adjusted R2 predicting slope of
same index
Adjusted R2 predicting slope
of MD
Adjusted R2 predicting slope of
same index
MD 0.14 0.14 0.17 0.17
LMS Linear-scaled
mean
0.13 0.14 0.15 0.08
CountG Garway-Heath 0.10 0.01 0.15 0.01
CountHa Harwerth 0.13 0.06 0.15 0.03
LossHo Hood 0.12 0.12 0.14 0.07
CountD Drasdo 0.09 0.13 0.14 0.09
CountDA Drasdo (age-
corrected)
0.08 0.08 0.13 0.10
LMS(cap) Linear-scaled
mean
0.12 0.20 0.16 0.18
CountG(cap) Garway-Heath 0.05 0.01 0.19 0.02
CountHa(cap) Harwerth 0.10 0.05 0.18 0.08
LossHo(cap) Hood 0.15 0.27 0.12 0.20
CountD(cap) Drasdo 0.04 0.03 0.11 0.07
CountDA(cap) Drasdo (age-
corrected)
0.06 0.22 0.11 0.13
Table 4
Spearman correlation coefﬁcients obtained when the baseline value of each global index is used to predict the rate of change, with associated p-values in brackets. Values in bold
were signiﬁcantly different from the model that used MD to predict subsequent slope of MD (p < 5%). The indices labeled ‘cap’ are calculated after pointwise sensitivities were
capped at the age-corrected normal value.
Baseline index Based on model from Participants with GON Participants without GON
Correlation with
slope of MD
Correlation with slope
of same index
Correlation with
slope of MD
Correlation with
slope of same index
MD 0.34 (p = 0.02) 0.34 (p = 0.02) 0.09 (p = 0.55) 0.09 (p = 0.55)
LMS Linear-scaled mean 0.45 (p < 0.01) 0.37 (p = 0.01) 0.21 (p = 0.16) 0.12 (p = 0.45)
CountG Garway-Heath 0.41 (p < 0.01) 0.13 (p = 0.37) 0.25 (p = 0.10) 0.00 (p = 1.00)
CountHa Harwerth 0.41 (p < 0.01) 0.32 (p = 0.02) 0.21 (p = 0.16) 0.13 (p = 0.38)
LossHo Hood 0.35 (p = 0.01) 0.25 (p = 0.08) 0.09 (p = 0.56) 0.00 (p = 0.98)
CountD Drasdo 0.42 (p < 0.01) 0.36 (p = 0.01) 0.18 (p = 0.23) 0.01 (p = 0.97)
CountDA Drasdo (age-corrected) 0.32 (p = 0.02) 0.25 (p = 0.08) 0.10 (p = 0.52) 0.10 (p = 0.52)
LMS (cap) Linear-scaled mean 0.40 (p < 0.01) 0.39 (p = 0.01) 0.24 (p = 0.11) 0.39 (p = 0.01)
CountG (cap) Garway-Heath 0.32 (p = 0.03) 0.14 (p = 0.32) 0.27 (p = 0.07) 0.21 (p = 0.16)
CountHa (cap) Harwerth 0.35 (p = 0.02) 0.31 (p = 0.03) 0.23 (p = 0.13) 0.39 (p = 0.01)
LossHo (cap) Hood 0.43 (p < 0.01) 0.57 (p < 0.01) 0.05 (p = 0.73) 0.48 (p < 0.01)
CountD (cap) Drasdo 0.30 (p = 0.04) 0.24 (p = 0.10) 0.09 (p = 0.56) 0.04 (p = 0.81)
CountDA (cap) Drasdo (age-corrected) 0.38 (p = 0.01) 0.59 (p < 0.01) 0.12 (p = 0.44) 0.32 (p = 0.03)
Table 5
Comparison of the baseline values of each index between those participants in the worst tertile of subsequent slope vs. the remaining participants. Values given are p-values from
a Wilcoxon’s rank sum test.
Baseline index Based on model from Participants with GON Participants without GON
Compare tertiles
of slope of MD
Compare tertiles of
slope of same index
Compare tertiles
of slope of MD
Compare tertiles of
slope of same index
MD 0.03 0.03 0.99 0.99
LMS Linear-scaled mean <0.01 0.04 0.43 0.80
CountG Garway-Heath <0.01 0.96 0.60 0.61
CountHa Harwerth <0.01 0.05 0.45 0.73
LossHo Hood 0.02 0.03 0.26 0.36
CountD Drasdo <0.01 0.01 0.25 0.59
CountDA Drasdo (age-corrected) 0.02 0.09 0.20 0.21
LMS (cap) Linear-scaled mean <0.01 <0.01 0.18 <0.01
CountG (cap) Garway-Heath <0.01 0.02 0.24 0.38
CountHa (cap) Harwerth <0.01 <0.01 0.35 0.01
LossHo (cap) Hood 0.01 <0.01 0.95 0.01
CountD (cap) Drasdo 0.01 0.18 0.77 0.08
CountDA (cap) Drasdo (age-corrected) 0.03 <0.01 0.80 0.10
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were based on the same index; LMS(cap), CountHa(cap) and
LossHo(cap).
Table 6 presents Nagelkerke pseudo-R2 values from the logistic
regression analysis, in which baseline values of each index were
used to predict whether a participant would be in the worst tertile
for subsequent rate of change.
Fig. 1 shows plots of baseline value against subsequent slope for
MD and two of the indices, LMS(cap) and LossHo(cap). Fig. 2 shows
plots that compare the rates of change by MD and LossHo(cap), both
as actual values and when the ranks of the rates are compared.
Mostly the same eyes are identiﬁed by both indices as being rapid
progressors.4. Discussion
This manuscript is part of a study designed to improve esti-
mates of the level of functional damage in glaucoma, and to predict
which patients are likely to undergo rapid progression. Here, we
examine linear-based indices from visual ﬁeld sensitivities in such
predictive models. Speciﬁcally, in this study we assessed partici-
pants with early or suspected glaucoma, and examine the relation
between baseline parameters and subsequent rate of functionalTable 6
Nagelkerke pseudo-R2 index for models that used the baseline value of each index to pred
change. Backwards-elimination logistic regression was used as outlined in Section 2. The in
corrected normal value.
Baseline index Based on model from Participants with GON
R2 predicting tertile
of slope of MD
R2
of
MD 0.33 0.
LMS Linear-scaled mean 0.34 0.
CountG Garway-Heath 0.35 0.
CountHa Harwerth 0.35 0.
LossHo Hood 0.34 0.
CountD Drasdo 0.34 0.
CountDA Drasdo (age-corrected) 0.34 0.
LMS (cap) Linear-scaled mean 0.31 0.
CountG (cap) Garway-Heath 0.29 0.
CountHa (cap) Harwerth 0.30 0.
LossHo (cap) Hood 0.34 0.
CountD (cap) Drasdo 0.28 0.
CountDA (cap) Drasdo (age-corrected) 0.28 0.
Fig. 1. The subsequent rate of change over years 2–7 of the sequence, plotted against ba
Deviation (MD), Capped Linear Mean Sensitivity (LMS(cap)), and Capped RGC Loss accord
are decibels, the scales on the axes differ, since the indices took values over differen
glaucomatous optic neuropathy at their initial visit.change when using linear-scaled indices. Several issues arise from
such a study, each worthy of further consideration.
Increased damage to the visual ﬁeld was found to be predictive
of a more rapid subsequent rate of progression. There are several
possible explanations for this ability of the current value of an in-
dex to predict the rate of subsequent change:
 The rate of change is not truly linear over time. This may be
because the rate varies substantially during the series; or may
be because the scale used to measure sensitivity is sub-optimal.
If damage ‘accelerates’ on a dB scale, this would cause an appar-
ent correlation between current status and subsequent rate of
change. This issue is discussed further in Section 4.4.
 Participants had already undergone some damage before enter-
ing the study. For example, suppose that two patients were
enrolled 2 years after onset of damage, having previously had
identical healthy visual ﬁelds. Of these two patients, the one
progressing at the fastest rate will have a worse visual ﬁeld
upon study entry, causing an apparent correlation between
‘baseline’ (i.e. study entry) and subsequent rate of change. How-
ever, there are many factors inﬂuencing time of entry into the
study, such as the date of ﬁrst diagnosis; not all patients will
have entered the same amount of time after onset of damage.
These factors will dilute any such effect.ict the probability of the participant being in the worst tertile of subsequent rate of
dices labeled ‘cap’ are calculated after pointwise sensitivities were capped at the age-
Participants without GON
predicting tertile
slope of same index
R2 predicting tertile
of slope of MD
R2 predicting tertile
of slope of same index
33 0.31 0.31
35 0.29 0.26
04 0.28 0.22
22 0.28 0.07
36 0.28 0.27
18 0.26 0.28
12 0.26 0.29
18 0.31 0.50
09 0.30 0.10
21 0.31 0.19
34 0.34 0.65
04 0.24 0.29
33 0.31 0.29
seline value in year 1, for three of the global indices considered in this study; Mean
ing to the model by Hood et al. (LossHo(cap)). Note that while the units for all indices
t ranges. Shading of the data points indicates whether the participant exhibited
Fig. 2. Comparison of the rates of change in Mean Deviation (MD) and in the Capped RGC Loss according to the model by Hood et al. (LossHo(cap)). The left plot compares the
actual rates of change (slope of linear regression over time); the right plot compares the ranks of the rates.
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sives, but have not developed actual glaucomatous damage
and possibly never will. These participants will have normal
ﬁelds, and little or no subsequent change, using current testing
and analysis methods. This would again cause an apparent cor-
relation between damage and more rapid subsequent change.
However, all such participants would be expected to be within
the non-GON cohort, so this is unlikely to explain the relation
found among participants with GON at baseline.
It may be considered likely that the relation is in fact due to a
combination of these factors.
Differences were found in the abilities of indices to predict sub-
sequent change in that same index.
 Predictability of an index will be inﬂuenced by the manner in
which it changes over time. If the relation between the index
value and its rate of change is close to linear in one index, this
could result in the initial value of that index appearing to be
more predictive. By contrast, if the index changed absolutely
linearly over time, its initial value would only derive any predic-
tive value from the possibility that a patient with worse damage
upon presentation may have developed glaucoma at the same
date, but undergone more rapid progression since then. It
should also be noted that all indices were expressed on a loga-
rithmic scale before the comparisons were conducted, and so
there may not be much difference in linearity between indices.
 Some of the indices exaggerate variability at locations that are
still within the normal range; while others reduce this point-
wise variability. In particular, capping sensitivities aims to
reduce this normal variability to improve the signal-to-noise
ratio; this is discussed further in Section 4.2.
 Models of the structure–function relation that adjust for eccen-
tricity-related changes may improve the ability of an index to
reﬂect the true density of remaining RGCs. However, as dis-
cussed in Section 4.3, it may also have an unintended and less
welcome side-effect, by increasing the effect of pointwise vari-
ability at more central locations.
 The testing algorithm (SITA standard in this study) could
increase the variability in some indices more than others. As
discussed below, the SITA standard algorithm is designed to
reduce pointwise measurement errors on a dB scale. However,
linear-based algorithms, or algorithms where the density of test
locations varies with eccentricity, may improve the perfor-
mance of speciﬁc indices. Appropriate global indices should be
one of the factors considered when choosing testing algorithms.
Again, these possibilities are not mutually exclusive, and it
would seem likely that a combination of different factors affects
the overall results.4.1. Predictability
No single measurement accurately predicted the future rate of
change. Clinical decisions will be made on the basis of several
sources of information, rather than just one index as used in this
study. The weighting that is applied to each source of clinical infor-
mation will also inﬂuence management decisions. However,
improving the accuracy of any important source of information
should have a beneﬁcial effect on the overall prediction of progres-
sion. Obtaining and quantifying such an improvement in isolation
from other factors, as in this study, produces ﬁndings that can then
be incorporated into more complete prediction models in the
future.
An example of a more realistic prediction model would be one
that uses the index value at visit 1, and the change in that index
between visits 1 and 2, together with IOP, age, current treatment
status, and the determination of whether the participant exhibited
GON. A clinician could seek to use this information to predict the
rate of change of MD over visits 1–7. When a regression was car-
ried out with this model, IOP and treatment status turned out
not to be signiﬁcant predictors of outcome. When MD at visits 1
and 2 is used as the predictor, this model achieves an adjusted R-
squared of 26%. When LossHo(cap) is used as the predictor, the ad-
justed R-squared of the model is 30%. When LossHo(cap) is used in
this way to predict the rate of change of itself, rather than MD, the
adjusted R-squared of the model rises to 52%. This analysis con-
tains statistical bias, since an increased value of an index at visit
1 will cause the rate of change over visits 1–7 to be more negative.
However, it demonstrates the potential utility of these linear-
based indices in a more clinically realistic situation.
We focus not on an attempt to distinguish ‘progressing’ from
stable participants, as this requires an arbitrary deﬁnition of what
constitutes ‘progression’. Methods such as pointwise linear regres-
sion (Fitzke, Hitchings, Poinoosawmy, McNaught, & Crabb, 1996;
Gardiner & Crabb, 2002; Viswanathan, Fitzke, & Hitchings, 1997),
and indices related to irregularities of the visual ﬁeld such as
PSD and the Glaucoma Hemiﬁeld Test (GHT) can evaluate the char-
acteristic patterns of loss corresponding to retinal nerve ﬁber layer
defects, and can be used to identify deepening of existing scoto-
mas. However, they have a more limited ability to detect general-
ized loss of function. It has been reported that pattern deviation
analyses, which adjust for generalized visual ﬁeld loss, underesti-
mate the occurrence and severity of progression (Artes, Nicolela,
LeBlanc, & Chauhan, 2005; Artes et al., 2010). By contrast, global
measures of ‘overall sensitivity’ such as MD may be less useful
for the initial identiﬁcation of glaucomatous damage, in part be-
cause a reduction in these indices could be the result of other
pathologies such as cataract and in part because the contribution
of very small defects may be diluted if the majority of the visual
ﬁeld is still normal. However, they are also sensitive to worsening
Table 7
Spearman correlation coefﬁcients obtained when the baseline value of each global
index is used to predict the rate of change, as in Table 4, in two subsets of the dataset.
Baseline
index
Participants with MD < 0 dB Participants with MD < 1 dB
Correlation
with slope
of MD
Correlation
with slope of
same index
Correlation
with slope
of MD
Correlation
with slope of
same index
MD 0.13 0.13 0.39 0.39
LossHo 0.17 0.09 0.32 0.20
LossHo
(cap)
0.33 0.35 0.50 0.53
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locations in glaucomatous eyes than in normal eyes, as opposed
to the susceptibility being higher at some locations but the same
as normal elsewhere, then these indices may also be more predict-
able over time. Although in this study only global measures of
‘overall sensitivity’, analogous to MD, were considered, as a next
step the same techniques will be used to generate linear pattern
indices analogous to PSD.
There are several possible explanations for the relatively weak
correlations observed between a participant’s current status and
their subsequent rate of change. The dataset consisted of partici-
pants with very early glaucoma or (in many cases) only ocular
hypertension, which limits the range of individual values. It may
be that participants with more severe disease would have resulted
in greater predictability, without the confounding variability
caused by high-risk individuals who may never develop glaucoma.
Certainly, if it were the case that current status does indeed predict
future rate of change, a wider range of rates of change would be ex-
pected to result in stronger correlations. A problem more speciﬁc
to this particular dataset is that not all participants were following
the same treatment regimen. Indeed, participants seen to be pro-
gressing more rapidly will most likely have been prescribed more
aggressive treatment by their clinician, with the intent of reducing
their subsequent rate of change. This would decrease any true cor-
relation between worse initial status and worse subsequent rate of
change. At year 1, 45% of participants in the GON cohort reported
that they were undergoing treatment for ocular hypertension,
and 19% of the non-GON cohort (although this is based purely on
self report, with no means to assess compliance). These caveats
lead us to believe that we may be underestimating the true predic-
tive ability of current status, but further studies will be needed to
conﬁrm or refute this.
4.2. Capping sensitivities
For each new index used, we also calculated a ‘capped’ index, in
which the sensitivity at each location in the ﬁeld was set to equal
no more than the age-corrected normal value. The aim behind
these capped indices is to reduce the problematic variability ob-
served at normal and above-normal sensitivities, without affecting
the true signal from below-normal sensitivities in damaged areas
of the ﬁeld. There is considerable variability among normal eyes.
The relation between retinal nerve ﬁber layer thickness (a pre-
sumed surrogate for RGC count) and sensitivity in normal eyes is
weak (Hood et al., 2007). Variability in undamaged areas repre-
sents a greater problem when expressed on a linear scale, since
the SITA standard algorithm (Bengtsson et al., 1997) used for deter-
mining sensitivity is designed to minimize errors on a dB scale. As
pointed out in Section 2, a 2 dB measurement error when the sen-
sitivity is 34 dB corresponds to an error of 1470 linear (1/contrast)
units; whereas the same measurement error when the sensitivity
is 16 dB corresponds to an error of only 23 units on the same linear
scale. Therefore when values from different locations are summed
or averaged (before converting the resultant total back to the dB
scale), the variability at a location with near-normal sensitivity will
have more of an inﬂuence on the index than the variability at a
damaged location in the same eye.
The capping performed in this study is very simplistic. Partici-
pants whose sensitivities are initially above the age-corrected nor-
mal value could progress for some time without any change
occurring in the capped indices, particularly if the progression
was generalized rather than localized. An ideal capping system
would be individualized, such that the maximum pointwise sensi-
tivity would be based on that expected in that particular partici-
pant in the absence of damage. However, there is currently no
way of knowing what a participant’s ‘‘healthy’’ sensitivity wouldbe. An approximation could be calculated by comparing undam-
aged areas of their visual ﬁeld with the normal hill of vision; yet
there is no way of knowing that an area (or even the fellow eye)
is truly undamaged, especially given the possibility of generalized
sensitivity losses due to glaucoma (Artes et al., 2010; Henson,
Artes, & Chauhan, 1999).
Despite the simplistic nature of the process used here, there
was still some evidence that capping may improve the ability to
predict subsequent change. For example, LossHo(cap) frequently
outperformed the uncapped LossHo. The question then arises as
to how much of this effect is due to a genuine reduction in the var-
iability of the index, and how much is purely a mathematical arte-
fact caused by participants with consistently above-normal
sensitivities throughout the study period (who would exhibit a
baseline index value equal to the capped maximum, and zero sub-
sequent rate of change). To address this, we repeated the analysis
used to generate Table 4 to calculate the correlation between base-
line index value and subsequent rate of change for three of the
indices, ﬁrstly among participants (from either the GON or non-
GON cohorts) with a baseline MD < 0 dB, and secondly among par-
ticipants with baseline MD < 1 dB. In all, 32 and 52 participants
satisﬁed these respective criteria. Results are shown in Table 7.
Although differences between the indices were not signiﬁcant in
this case, we believe that the observed improvement in predict-
ability using the capped version of LossHo supports our assertion
that at least part of the beneﬁts of capping is genuine and not
merely artefactual.
Any beneﬁts of capping in reducing the variability of an index
may not be present in participants with more advanced disease.
Future reﬁnement of the capping process must take into account
the need to be able to utilize the procedure in eyes at different
stages of the disease and/or with coexisting ocular pathologies.
An alternative approach to reducing the effect of variability in
near-normal regions of the visual ﬁeld could be to use testing algo-
rithms based on the linear scale instead of SITA standard, so that
measurement errors in these regions (when expressed in linear
units) are no longer disproportionately large when compared to
those at damaged locations. It is possible that this could reduce
or remove the beneﬁts of using capped global indices. More likely,
it would improve the predictability of linear-based indices by
reducing their variability. Due to this issue, any beneﬁts of using
the new indices described in this paper over the established indices
may be underestimated. A linear staircase testing algorithm has
been described (Malik, Swanson, & Garway-Heath, 2006), and fur-
ther work extending this concept is warranted.4.3. Adjusting for eccentricity
The models of Garway-Heath et al. (2000), Harwerth and Quig-
ley (2006) and Harwerth et al. (2004) both contain a fundamental
difference from that of Hood (2007), Hood and Kardon (2007) and
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ing RGC counts. This may indeed make them more accurate in
terms of relating structure to function, which is the purpose for
which all the models were designed, as normal sensitivities differ
with eccentricity. However, when averaging across locations, this
eccentricity term causes some locations to receive greater weight-
ing than others, causing the variability of the ﬁnal index to in-
crease. This causes the variability about CountG(cap) and
CountHa(cap) to be increased, which would be expected to make
them less predictable than indices such as LossHo(cap) that weight
all test locations equally. There is some evidence for this in Section
3, where LossHo(cap) exhibited higher correlations than these two
alternatives when used as a predictor of the subsequent change in
the same index.
As an illustration, let us assume that the variability is constant
across the visual ﬁeld (for a given sensitivity level) (Henson, Chau-
dry, Artes, Faragher, & Ansons, 2000) with standard deviation r.
When all 52 locations have equal weight, their average has vari-
ance r2/52. However, an index = 1.5  (Sens1 +  + Sens26) + 0.5 
(Sens27 +  + Sens52) with varying weights has variance (26 
1.52 + 26  0.52)  r2/522 = 1.25  r2/52; in other words, 25% high-
er. In reality, pointwise sensitivity and variability vary across the
visual ﬁeld, so the true increase in index variability caused by
eccentricity weighting will not be as simple to calculate as in this
example.
In order to negate this effect, and reduce the variability present
in eccentricity-weighted indices, it is necessary to reduce the var-
iability in the (higher weighted) central region of the ﬁeld. This
could be done by increasing the proportion of stimulus presenta-
tions that are made in the central regions, so that these sensitivity
estimates have a smaller measurement error (in dB) than those in
the periphery. Ideally, the measurement error in the estimate of
the RGC count (and hence, in the linear-scaled sensitivity) should
be constant across locations. An alternative method would be to
employ a testing pattern that is denser in the center than in the
periphery (i.e. more testing locations per unit area). The contribu-
tion to the total RGC count from each test location would then be
more equal across sensitivities. Such testing grids are available on
the Octopus 900 perimeter (Haag Streit International, Koeniz, Swit-
zerland), although they are not optimized for this particular pur-
pose; they are not currently available on the Humphrey Field
Analyzer.
It should be noted that indices containing corrections for eccen-
tricity might be optimal for other purposes, even if higher-
weighted central locations are not measured more accurately than
peripheral locations. Our results should not be taken as an indica-
tion as to which model is more accurate for studying the cross-sec-
tional structure–function relationship.
4.4. Linearity of progression
While MD is based on a dB scale, the other indices transform
sensitivities/RGC counts onto a linear scale before averaging over
locations, and then transforming back to a dB scale to produce
the ﬁnal index value. If the proportion of RGCs lost per unit time
remains constant, this would result in a straight line on a plot of
the index (in dB) against time. Coefﬁcients obtained from linear
regression over time then provide the appropriate measure of the
rate of change.
However, the assumption that the proportionate rate of RGC
loss remains constant throughout the disease is a simpliﬁcation
(Caprioli et al., 2010). It is possible that in fact the actual number
of RGCs lost per unit time remains constant, in which case linear
regression of indices expressed in linear units would be more
appropriate; this would result in progression appearing to acceler-
ate when expressed in dB units. The reality may well be some-where between these two extremes, with dB-scaled progression
accelerating but not by as much as would be predicted by a con-
stant rate of reduction in the RGCs count. Additionally, it may be
considered unlikely that the rate of loss (by whichever scaling is
chosen) would be consistent over time for any given eye; factors
such as spikes in IOP and short-term compliance with medications
could affect the rate in any given time period.
In this study, we used the structure–function models as de-
scribed in the original literature. These models are still being re-
ﬁned. Notably, it has been suggested that the structure–function
relation may change depending on disease stage (Gonzalez-Her-
nandez et al., 2009; Poinoosawmy, Fontana, Wu, Fitzke, & Hitch-
ings, 1997). Harwerth and colleagues have suggested that the
relation between retinal nerve ﬁber layer thickness and RGC count
varies with disease stage (Harwerth, Wheat, Fredette, & Anderson,
2010). The index CountG was constructed assuming that spatial
summation remains constant throughout the disease process,
which may not be the case (Garway-Heath et al., 2000; Redmond,
Garway-Heath, Zlatkova, & Anderson, 2010). Such reﬁnements to
the models may result in more accurate measurement of RGC
count, and hence progression, in the future.5. Conclusions
Participants with worse baseline visual ﬁelds were more likely
to undergo more rapid subsequent loss of function in most, but
not all, indices, presumably caused by glaucomatous progression,
even after other risk factors such as age and IOP were adjusted
for. This was especially true among eyes that already exhibited
GON. This is an important problem facing clinicians; namely,
determining whether a high-risk glaucoma suspect is likely to pro-
gress rapidly and require more aggressive management. Use of lin-
ear-based indices might in the future improve the assessment of
the current status of the ﬁeld, providing the clinician with a more
accurate measurement of this risk factor. However, there are many
issues to be overcome before an optimal index can be derived. The
choice of index will likely depend on the purpose intended. For
optimal performance, testing algorithms and patterns may need
to be adjusted to reduce the variability present in a speciﬁc global
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